Skip to content

Effectiveness of the creative space for mental health program in improving the quality of life of users of psychiatric services

Effectiveness of the creative space for mental health (CSMH) program in improving the quality of life of users of psychiatric services: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12436326
Enrollment
60
Registered
2021-07-29
Start date
2021-08-01
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of life in psychiatric patients with psychotic spectrum disorders Mental and Behavioural Disorders Schizophrenia, schizotypal and delusional disorders

Interventions

The research aims to test the effectiveness of the Creative Space for Mental Health program (Program) in improving the quality of life of psychiatric patients, which patients of the Institute for Ment

Sponsors

Psychosocial Innovation Network
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age minimum of 18 years 2. Diagnosed with psychotic spectrum disorders (ICD-10 F20-F29) 3. Capacity and willingness to participate in Program’s activities during the intervention period and go through psychological assessment 4. Able and willing to give informed consent 5. Native or fluent in Serbian

Exclusion criteria

Exclusion criteria: Participants are excluded if: 1. They were previously diagnosed with personality disorder, organic mental disorder, or intellectual disability 2. Can’t participate in group activities 3. Were legally mandated to undergo psychiatric treatment

Design outcomes

Primary

MeasureTime frame
Subjective perception of quality of life measured using an SQOL questionnaire at baseline, post-treatment (after 3 months) and follow up (after 6 months)

Secondary

MeasureTime frame
Measured at baseline, post-treatment (after 3 months) and at follow up (after 6 months): 1. Severity of symptoms of depression, anxiety and stress measured by Depression, Anxiety and Stress Scale - 21 Items (DASS-21), short version 2. Severity of psychiatric symptoms measured by the brief psychiatric rating scale 3. Level of hope measured by the Herth Hope Index (HHI) 4. Objective indicators of social outcomes assessed by the objective social outcomes index (SIX)

Countries

Serbia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026